Francesco Scavello obtained a double PhD in Life Sciences and Physics-Physical Chemistry from University of Calabria and University of Strasbourg, dissecting the role of Chromogranin A-derived antimicrobial peptides in cardiac inflammation and nosocomial infections.
During his first post-doc period at IRCCS Centro Cardiologico (Milan), he studied the role of Soluble Receptor for Advanced Glycation End-products in cardiac aging and Inflammaging. At the moment, Dr. Scavello covers a post-doc position in the Laboratory of Experimental Immunopathology at Humanitas Research Hospital. He studies the role of the long Pentraxins (PTXs) in the response to COVID-19 and bacterial or fungal infections, focusing also on the validation of PTX3 as an early biomarker for COVID-19 acute and chronic complications, such as secondary infections and cardiovascular complications. His research interests also include the crosstalk between the immune system, cancer and cardiovascular diseases. In particular, these studies aim to elucidate the role of negative regulators of inflammatory responses, such as IL-1R8, in the context of chemotherapy treatments, both in terms of cancer growth and adverse cardiovascular events.